PYC pyc therapeutics limited

Ann: CEO letter and Operational Update, page-17

  1. 234 Posts.
    lightbulb Created with Sketch. 37
    Andrew I'm not overly concerned about obtaining tissue specific absorption with systemic administration. Too difficult to achieve. The alternative is to deliver a promising choice via direct arterial organ cannulation as with dye injection for angiograms, though repeated administration could be an issue under that scenario.
    Are there any drugs currently in use that have organ/tissue specific pharmacokinetics that do not depend on cell receptors?

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.15
Change
0.020(1.77%)
Mkt cap ! $670.7M
Open High Low Value Volume
$1.15 $1.18 $1.11 $172.3K 151.3K

Buyers (Bids)

No. Vol. Price($)
1 592 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 4211 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.